Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neuronetics Inc (NQ: STIM ) 0.8600 -0.0600 (-6.52%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Neuronetics Inc < Previous 1 2 Next > Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents September 25, 2024 Policy update increases access for millions covered by HCSC BlueCross BlueShield policies From Neuronetics Via GlobeNewswire Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults September 19, 2024 BlueCross BlueShield of North Carolina and Louisiana Medicaid Increase Coverage for Patients with Depression From Neuronetics Via GlobeNewswire NeuroStar® Releases Software Upgrades to Elevate Patient Care September 16, 2024 Upgrades improve communication, streamline data management, and strengthen security From Neuronetics Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enstar Group Limited (Nasdaq – ESGR), PetIQ, Inc. (Nasdaq – PETQ), Greenbrook TMS, Inc. (OTC – GBNHF), GSE Solutions, Inc. (Nasdaq – GVP) September 06, 2024 From Brodsky & Smith LLC Via GlobeNewswire NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories September 03, 2024 NeuroStar Is More Than Halfway to Achieving Its Five-Year Goal of Saving Thousands of Lives From Neuronetics Via GlobeNewswire NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University August 20, 2024 Celebrating milestones in patient care and practice enhancement through NeuroStar’s innovative training facility From Neuronetics Via GlobeNewswire NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month August 01, 2024 New initiative aims to provide information and resources for teen mental health amidst rising public health concerns From Neuronetics Via GlobeNewswire Aetna Policy Update Expands TMS Availability for Adolescents With Depression July 22, 2024 Coverage criteria consistent with recent FDA clearance for NeuroStar TMS From Neuronetics Via GlobeNewswire California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults July 11, 2024 NeuroStar, the first and only TMS treatment cleared for adolescents, now covered by Medi-Cal From Neuronetics Via GlobeNewswire BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents July 10, 2024 Updated criteria post-FDA clearance for NeuroStar TMS benefit youth mental health From Neuronetics Via GlobeNewswire NeuroStar® Launches Better Me Provider Program Nationwide July 01, 2024 The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry From Neuronetics Via GlobeNewswire NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting June 13, 2024 Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024 From Neuronetics Via GlobeNewswire Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents May 15, 2024 Policy change comes quickly after FDA clearance for NeuroStar TMS use in ages 15 and older From Neuronetics Via GlobeNewswire NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month May 01, 2024 The Company is highlighting stories from adolescents with major depressive disorder on the heels of groundbreaking FDA clearance From Neuronetics Via GlobeNewswire New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital April 10, 2024 Lack of early symptom improvement is not predictive of final responder status From Neuronetics Via GlobeNewswire NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression March 25, 2024 NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older From Neuronetics Via GlobeNewswire Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network March 07, 2024 From Neuronetics Via GlobeNewswire Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System February 12, 2024 Advancements provide workflow efficiencies for NeuroStar® TMS providers From Neuronetics Via GlobeNewswire NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update February 06, 2024 Criteria Change Reduces Requirements for Treatment Accessibility From Neuronetics Via GlobeNewswire Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory December 18, 2023 New accessory for NeuroStar TMS reduces patient setup steps and improves efficiency for providers From Neuronetics Via GlobeNewswire NeuroStar TMS Receives Expanded Regulatory Approval in Japan December 04, 2023 Technological advances reduce time and increase efficiency for MDD treatment From Neuronetics Via GlobeNewswire NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements November 13, 2023 New updates designed to advance practice efficiency and patient outcomes From Neuronetics Via GlobeNewswire Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage November 09, 2023 Policy Updates from Magellan and Two Additional Payors Increase Access for 3.2 Million Covered Lives From Neuronetics Via GlobeNewswire Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes October 16, 2023 Findings confirm strong correlation between the number of TMS treatment sessions completed and improvement in MDD From Neuronetics Via GlobeNewswire In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression September 12, 2023 Portal provides resources to raise awareness around mental health and suicide prevention From Neuronetics Via GlobeNewswire NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards August 21, 2023 Award Acknowledges Excellence in Digital Marketing Efforts From Neuronetics Via GlobeNewswire Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform August 14, 2023 New automated features elevate the standard of care for NeuroStar® Advanced Therapy practices From Neuronetics Via GlobeNewswire Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans July 19, 2023 Policy Updates Impact Nationwide Commercial Plans for 16.8 Million Covered Lives From Neuronetics Via GlobeNewswire NeuroStar Achieves Milestone Regulatory Clearance in South Korea July 17, 2023 First International Approval for Expanded Indication and Certification for MT Cap and D-Tect™ Technologies From Neuronetics Via GlobeNewswire NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player July 11, 2023 Award Recognizes Efforts to Raise Awareness Around Non-Drug Depression Treatment From Neuronetics Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.